Showing results (91-100 of 341) with videos related to

Sort By:
Pageof 35
Contemporary Clinical Trials|November 22, 2007
Quality management of a large randomized double-blind multi-centre trial: the ACTION experienceBridget-Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer, et al.
The New England Journal of Medicine|November 16, 2010
Eplerenone in patients with systolic heart failure and mild symptomsFaiez Zannad, John J V McMurray, Henry Krum, et al.
JAMA|September 24, 2004
Physical activity, including walking, and cognitive function in older womenJennifer Weuve, Jae Hee Kang, JoAnn E Manson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 23, 2020
Prioritised endpoints for device-based hypertension trials: the win ratio methodologyDavid E Kandzari, Graeme L Hickey, Stuart J Pocock, et al.
European Journal of Heart Failure|December 27, 2021
Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-ReducedJoão Pedro Ferreira, Stefan D Anker, Javed Butler, et al.
European Heart Journal|December 8, 2021
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fractionJaved Butler, Milton Packer, Gerasimos Filippatos, et al.
JAMA Cardiology|September 21, 2022
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-PooledJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
Journal of the American College of Cardiology|April 3, 2010
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient dataKeith A A Fox, Tim C Clayton, Peter Damman, et al.
Circulation|August 25, 2023
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart FailureMilton Packer, Javed Butler, Cordula Zeller, et al.
European Journal of Heart Failure|May 23, 2022
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitionsStefan D Anker, Tariq Jamal Siddiqi, Gerasimos Filippatos, et al.
Pageof 35